NCT04817982View on ClinicalTrials.gov

Does Perineural Dexamethasone Increase the Duration of an Ulnar Nerve Block When Controlling for Systemic Effects?

PHASE2CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

April 7, 2021

Primary Completion Date

May 15, 2021

Study Completion Date

May 15, 2021

Conditions
Anesthesia, Local
Interventions
DRUG

Perineural dexamethasone

Dexamethasone 4mg will be added perineurally to an ulnar nerve block with bupivacaine.

DRUG

Lidocaine

Lidocaine 40 mg will be added perineurally to an ulnar nerve block with bupivacaine.

DRUG

Placebo

Saline will be added perineurally to an ulnar nerve block with bupivacaine.

DRUG

Systemic dexamethasone

Dexamethasone will be added perineurally to an ulnar nerve block with bupivacaine, some will be reabsorbed and distributed systemically. Thereby, the investigators control for the systemic effects of adding perineural dexamethasone to an ulnar nerve block.

Trial Locations (1)

4600

Zealand University Hospital, Køge

All Listed Sponsors
lead

Zealand University Hospital

OTHER

NCT04817982 - Does Perineural Dexamethasone Increase the Duration of an Ulnar Nerve Block When Controlling for Systemic Effects? | Biotech Hunter | Biotech Hunter